Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CYCLOBENZAPRINE | 10MG | TABLET | Resolved | 2024-03-28 | 2024-05-03 | 223838 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2020-04-23 | 2020-05-21 | 113028 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2021-01-07 | 2021-02-05 | 131066 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2021-07-22 | 2021-09-30 | 142902 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2022-01-27 | 2022-02-25 | 153742 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2022-03-10 | 2022-05-19 | 156410 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2022-12-01 | 2022-12-15 | 176788 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-02-16 | 2023-08-04 | 184931 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-06-19 | 2023-07-05 | 195563 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-11-16 | 2023-11-23 | 210431 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-12-07 | 2024-03-21 | 212730 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Actual shortage | 2024-05-16 | 2024-05-30 | 228149 |
TEVA-CYPROTERONE / ETHINYL ESTRADIOL | 0.035MG 2MG | TABLET | Resolved | 2019-06-27 | 2019-08-24 | 87696 |
TEVA-CYPROTERONE / ETHINYL ESTRADIOL | 2MG 0.035MG | TABLET | Resolved | 2020-04-10 | 2020-05-29 | 111857 |
TEVA-CYPROTERONE / ETHINYL ESTRADIOL | 0.035MG 2MG | TABLET | Resolved | 2021-04-29 | 2021-09-02 | 138297 |
TEVA-CYPROTERONE / ETHINYL ESTRADIOL | 0.035MG 2MG | TABLET | Resolved | 2023-06-08 | 2023-06-21 | 194128 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Resolved | 2019-10-17 | 2019-10-26 | 96730 |
TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Avoided shortage | 2019-11-21 | 2020-07-10 | 99453 |
TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Resolved | 2021-12-17 | 2022-02-05 | 151453 |
TEVA-DICLOFENAC SR | 75MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2018-10-23 | 2020-02-13 | 65490 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |